首页> 外文学位 >Biodegradable lactide polymers: Synthesis, degradation, and controlled drug release properties.
【24h】

Biodegradable lactide polymers: Synthesis, degradation, and controlled drug release properties.

机译:可生物降解的丙交酯聚合物:合成,降解和受控的药物释放特性。

获取原文
获取原文并翻译 | 示例

摘要

Biodegradable polylactide has been widely employed in medical and surgical applications, such as temporary tissue fixation, controlled drug release, and tissue engineering. Our investigation was aimed at obtaining a better understanding of polylactide synthesis, its degradation properties, the release mechanisms of water soluble drugs from a polylactide matrix, and the development of a biodegradable controlled antibiotic release device for treatment of bone infection in orthopaedic surgery. Biodegradable poly(DL-lactide), poly(L-lactide), poly(L-lactide-co-{dollar}epsilon{dollar}-caprolactone), and poly(DL-lactide-co-{dollar}epsilon{dollar}-caprolactone) were synthesized by a ring opening polymerization procedure. The drawability and melt processability of polylactide were modified by varying the polymer molecular weight and its distribution, and copolymerization of lactide with {dollar}epsilon{dollar}-caprolactone. The degradation study showed that polylactide was thermally unstable and its hydrolytic degradation rate was primarily affected by the degree of polymer purity. In order to obtain a biodegradable controlled antibiotic release device with promising properties, various matrix types of devices with different drug loadings were manufactured and tested in vitro. Coated PDLLA cylinders, with drug loadings below the percolation threshold, gave the most promising release properties in terms of a small initial burst, a gradual, and an easily adjustable release. The drug release mechanisms were found to be pure diffusion-through-channels, osmotic pressure induced diffusion-through-channels, and polymer degradation. Drug loading, drug particle size, and device length of the coated cylinder were three critical factors affecting the release properties. The coated cylindrical PDLLA device also gave good release profiles for delivery of the protein albumin, as well as the hormones testosterone and estradiol-17B. The significance of these studies is that they have increased our knowledge of biodegradable lactide polymers, particularly their synthesis, degradation, and applications in controlled drug release.
机译:可生物降解的聚丙交酯已广泛用于医疗和外科应用中,例如临时组织固定,受控药物释放和组织工程。我们的研究旨在更好地了解聚丙交酯的合成,其降解特性,水溶性药物从聚丙交酯基质中的释放机理,以及可生物降解的控制性抗生素释放装置的开发,该装置可用于骨科手术中的骨感染。可生物降解的聚(DL-丙交酯),聚(L-丙交酯),聚(L-丙交酯-共-{ε}ε{美元}-己内酯)和聚(DL-丙交酯-{-}εε)美元-己内酯)通过开环聚合方法合成。聚丙交酯的可拉伸性和熔体加工性通过改变聚合物分子量及其分布以及丙交酯与{ε}ε{ε}-己内酯的共聚反应而得到改善。降解研究表明,聚丙交酯是热不稳定的,其水解降解速率主要受聚合物纯度的影响。为了获得具有希望的性能的可生物降解的抗生素释放装置,制造了具有不同载药量的各种基质类型的装置,并在体外进行了测试。包衣的PDLLA气瓶的载药量低于渗漏阈值,以较小的初始破裂,逐渐释放和易于调节的释放方式提供了最有希望的释放特性。发现药物释放机理是纯的通过通道扩散,渗透压诱导的通过通道扩散和聚合物降解。药物载量,药物颗粒大小和涂层药筒的装置长度是影响释放特性的三个关键因素。包衣的圆柱形PDLLA装置还提供了良好的释放特性,可输送蛋白质白蛋白以及激素睾丸激素和雌二醇-17B。这些研究的意义在于,它们增加了我们对可生物降解的丙交酯聚合物的了解,尤其是它们的合成,降解以及在受控药物释放中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号